OncoDB.HCC: An integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci

Nucleic Acids Research

Volumn 35, Issue SUPPL. 1, 2007, Pages

  Su, Wen Hui ^a,d   Chao, Chuan Chuan ^d   Yeh, Shiou Hwei ^b   Chen, Ding Shinn ^b,c   Chen, Pei Jer ^b,c   Jou, Yuh Shan ^a,d  

^a NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; GENE EXPRESSION; GENE MAPPING; GENETIC DATABASE; HETEROZYGOSITY LOSS; HUMAN; INFORMATION PROCESSING; LIVER CELL CARCINOMA; MOLECULAR CLONING; NONHUMAN; ONCO DATABASE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNTENY; VALIDATION PROCESS;

RODENTIA;

EID: 84984578427     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl845     Document Type: Article

References (15)

1. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
2. Alaiya,A., Al-Mohanna,M. and Linder,S. (2005) Clinical cancer proteomics: Promises and pitfalls. J. Proteome Res., 4, 1213-1222.
3. Liang,P. and Pardee,A.B. (2003) Analysing differential gene expression in cancer. Nature Rev. Cancer, 3, 869-876.
4. Zhou,X., Rao,N.P., Cole,S.W., Mok,S.C., Chen,Z. and Wong,D.T. (2005) Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. Cancer Genet. Cytogenet., 159, 53-57.
5. Hanash,S. (2004) Integrated global profiling of cancer. Nature Rev. Cancer, 4, 638-644.
6. Tomlinson,I.P., Lambros,M.B. and Roylance,R.R. (2002) Loss of heterozygosity analysis: Practically and conceptually flawed? Genes Chromosomes Cancer, 34, 349-353.
7. Rhodes,D.R. and Chinnaiyan,A.M. (2005) Integrative analysis of the cancer transcriptome. Nature Genet., 37, S31-S37.
8. Albertson,D.G., Collins,C., McCormick,F. and Gray,J.W. (2003) Chromosome aberrations in solid tumors. Nature Genet., 34, 369-376.
9. Parkin,D.M., Bray,F., Ferlay,J. and Pisani,P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
10. Bosch,FX, Ribes,J., Diaz,M. and Cleries,R. (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology, 127, S5-S16.
11. Jou,Y.S., Lee,C.S., Chang,Y.H., Hsiao,C.F., Chen,C.F., Chao,C.C., Wu,L.S., Yeh,S.H., Chen,D.S. and Chen,P.J. (2004) Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma. Cancer Res., 64, 3030-3036.
12. Nishida,N., Nishimura,T., Ito,T., Korneda,J., Fukuda,Y. and Nakao,K. (2003) Chromosomal instability and human hepatocarcinogenesis. Histol. Histopathol., 18, 897-909.
13. Kim,J.W. and Wang,X.W. (2003) Gene expression profiling of preneoplastic liver disease and liver cancer: A new era for improved early detection and treatment of these deadly diseases? Carcinogenesis, 24, 363-369.
14. Thorgeirsson,S.S. and Grisham,J.W. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nature Genet., 31, 339-346.
15. Jeng,Y.M., Peng,S.Y., Lin,C.Y. and Hsu,H.C. (2004) Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin. Cancer Res., 10, 2065-2071.